During the past decade, Centre Léon Bérard - Hématologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Léon Bérard - Hématologie" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Institut de cancérologie Strasbourg Europe" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Centre Léon Bérard - Hématologie" are "Bruton Tyrosine Kinase Inhibitor" (1 trials), "CLL, Refractory" (1 trials), "CLL, Relapsed" (1 trials), "Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease" (1 trials) and "Fit Patients" (1 trials). Many other conditions were trialed in "Centre Léon Bérard - Hématologie" in a lesser frequency.

Most popular intervention types in "Centre Léon Bérard - Hématologie" are "Drug" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACA Continuation" (1 trials), "Blinatumomab" (1 trials), "Daratumumab" (1 trials), "Data registry" (1 trials) and "FCR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Léon Bérard - Hématologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Centre Léon Bérard - Hématologie". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centre Léon Bérard - Hématologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Léon Bérard - Hématologie, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".